No Detail Found!

Evaluation of agreement between point-of-care and laboratory automated immunoassay in procalcitonin measurement among critically ill patients

Author(s)
Muhamad Aizuddin Ismail Department of Anaesthesiology and Intensive Care, School of Medical Sciences,16150 Universiti Sains Malaysia, Kota Bharu, Kelantan,Malaysia
Mohd Zulfakar Mazlan Department of Anaesthesiology and Intensive Care, School of Medical Sciences,16150 Universiti Sains Malaysia, Kota Bharu, Kelantan,Malaysia
Shamsul Kamalrujan Hassan Department of Anaesthesiology and Intensive Care, School of Medical Sciences,16150 Universiti Sains Malaysia, Kota Bharu, Kelantan,Malaysia
Wan Norlina Wan Azman Department of Chemical Pathology, School of Medical Sciences,16150 Universiti Sains Malaysia, Kota Bharu, Kelantan, Malaysia
Tan Say Koon Department of Chemical Pathology, School of Medical Sciences,16150 Universiti Sains Malaysia, Kota Bharu, Kelantan, Malaysia
Najib Majdi Yaacob Department of Biostatistics and Research Methodology, School of Medical Sciences,16150 Universiti Sains Malaysia, Kota Bharu, Kelantan,Malaysia
Mahamarowi Omar Department of Anaesthesiology and Intensive Care, School of Medical Sciences,16150 Universiti Sains Malaysia, Kota Bharu, Kelantan,Malaysia
Nik Abdullah Nik Mohamad Department of Anaesthesiology and Intensive Care, School of Medical Sciences,16150 Universiti Sains Malaysia, Kota Bharu, Kelantan,Malaysia
Abstract
Introduction: Procalcitonin (PCT) has attracted significant attention as a novel biomarker of sepsis. This study aimed to assess the agreement between blood results of PCT, obtained using the Finecare™ FIA Meter Plus (FS113), a pointof-care (POC) procalcitonin testing device, and the automated Elecsys® BRAHMS PCT assay on the Cobas e411, among critically ill septic patients. Methodology: This observational study was conducted in the intensive care unit of Hospital Universiti Sains Malaysia, in 2021. Whole blood samples were collected and tested with the Finecare™ FIA Meter Plus (FS113) (Wondfo, China) for PCT measurement. Additionally, the same whole blood samples were centrifuged to produce plasma samples, which were then analyzed using the automated Elecsys® BRAHMS PCT assay on the Cobas e411 (Roche Diagnostics, Germany). Results: A total of 40 samples were analyzed in this study. Both PCT measurement techniques demonstrated a significant correlation, with a correlation coefficient of 0.96. Regression analysis revealed the following results: an Ordinary Least Square (OLS) slope of 0.91 (95% CI 0.83, 1.00) with an intercept of 1.27 (95% CI -0.75, 3.29); a Deming slope of 0.95 (95% CI 0.80, 1.10) with an intercept of 0.77 (95% CI -0.44, 1.85); and a Passing-Bablok slope of 1.16 (95% CI 0.99, 1.36) with an intercept of 0.22 (95% CI 0.08, 0.58). Conclusion: The point-of-care procalcitonin measurement provided by the Finecare™ FIA Meter Plus presents a viable alternative for assessing procalcitonin levels among septic patients in the intensive care unit (ICU).
Publication Details
Page(s) 470-477
Published Journal: Anaesthesia, Pain and Intensive Care, Volume: 27, Issue: 4, Year: 2023

Request the full text from PASTIC

Keywords
Intensive Care Unit, Sepsis, Procalcitonin, point of care
0

Citations

0

Downloads

51

Views